Lincoln, Nebraska, Dec. 10, 2018 (GLOBE NEWSWIRE) -- image002 National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a special dividend of fifty cents ($0.50) per share to shareholders of record as of the close of business on Monday, December 31, …

  • Updated

MORRISVILLE, N.C., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that John M. Dineen has been appointed to the Company’s Board of Directors and named Chairman of the Board. Dineen succeeds M…

BOSTON--(BUSINESS WIRE)--Dec 10, 2018--On December 10, 2018, Tekla World Healthcare Fund declared its monthly cash distribution of $0.1167 per share. The record date for the monthly cash distribution is December 20, 2018 and the payable date is December 31, 2018. The Fund will trade ex-distr…

BOSTON--(BUSINESS WIRE)--Dec 10, 2018--On December 10, 2018, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is December 20, 2018 and the payable date is December 31, 2018. The Fund will trade …

  • Updated

New York, New York, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Silverline, a Salesforce Platinum Consulting Firm headquartered in New York City, announced today that Geoff Merrick has joined Silverline as the new Senior Vice President and General Manager of Financial Services. As head of the Financia…

  • Updated

MIRAMAR, Fla.--(BUSINESS WIRE)--Dec 10, 2018--Generex Biotechnology Corporation (“Generex” or “Company”) ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) completed payment of its 20 to 1 common stock dividend on November 30, 2018.

  • Updated

NASHVILLE, Tenn.--(BUSINESS WIRE)--Dec 10, 2018--Cumberland announced today that its managed services offering has been fully rated by KLAS and boasts above market average scores in all key performance areas – value, relationship, product and operations. KLAS is the premier research organiza…

  • Updated

Kingwood, Texas, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Michael Marcroft joined the Vision Source senior leadership team on December 10, 2018. He will replace Randy Sones, currently Vice President of Marketing, who is retiring after a 27-year working history with Vision Source. As the Vice Presid…

  • Updated

MENLO PARK, Calif.--(BUSINESS WIRE)--Dec 10, 2018--GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the appointment of Catherine Friedman as Chair of the GRAIL Board of Directors. Ms. Friedman succeeds Bill Rastetter, who will c…

The Eastern Idaho Business Report: Keeping local businesses connected to each other and the community.

CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it has appointed Cynthia Collins to its Board of Directors.

  • Updated

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. successfully installed its new and innovative macro and micro APEX® Compounding System at Texas Children’s Hospital in Houston, Texas. The compounder is designed for facilities that need in-house compounding capabilities…

  • Updated

Culver City, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth markets, announced today that Mr. David Markowski CFO of EWLL was highlighted in a Proactive …

  • Updated

CHICAGO--(BUSINESS WIRE)--Dec 10, 2018--Ventas, Inc. (NYSE: VTR) said today that its Board of Directors declared the Company’s fourth quarter 2018 dividend, an increase to $0.7925 per share. The dividend is payable in cash on January 14, 2019 to stockholders of record on January 2, 2019. The…

  • Updated

BOSTON & OVERLAND PARK, Kan.--(BUSINESS WIRE)--Dec 10, 2018--TA Associates, a leading global growth private equity firm, today announced that it has signed a definitive agreement to invest, alongside GI Partners, in Netsmart Technologies, Inc. (“Netsmart” or “the Company”), a leading hea…

  • Updated

SAINT PETERSBURG, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations, and cannabis delivery technologies for the healthcare and consumer care industry, is pleased to a…

  • Updated

NEW HAVEN, Conn., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company focused on advancing its orally administered factor D complement inhibitors into late-stage development and commercialization, announced today that t…

  • Updated

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2019 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019. This will be a completely virtual meeting, conducted as…

  • Updated

SEATTLE--(BUSINESS WIRE)--Dec 10, 2018--Vein Clinics of America (“VCA”), a Frazier Healthcare Partners (“Frazier”) portfolio company, today announced that its Board of Directors has appointed Alton Shader as President and Chief Executive Officer effective December 10. Hans Thunem, VCA’s curr…

  • Updated

SAN FRANCISCO--(BUSINESS WIRE)--Dec 10, 2018--Twilio (NYSE:TWLO), the leading cloud communications platform, today announced that David Parry-Jones joined the company as the regional vice president of EMEA sales reporting to Twilio’s SVP of sales Marc Boroditsky.

  • Updated

KNUTSFORD, England--(BUSINESS WIRE)--Dec 10, 2018--The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creativ…

  • Updated

INCHEON, Korea--(BUSINESS WIRE)--Dec 8, 2018--Samsung Bioepis Co., Ltd. today announced the results of an additional one-year follow-up study comparing event-free survival (EFS) of SB3, a biosimilar candidate referencing HERCEPTIN ® 1 (trastuzumab), to reference trastuzumab (TRZ) by antibody…